Medico Remedies credit ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023
18.818.814.78.19.8
15.115.112.26.57.6
0.25×0.25×0.24×0.15×0.22×
0.20×0.20×0.20×0.12×0.17×
1.11×1.11×0.98×0.62×1.01×
0.86×0.89×0.81×0.50×0.79×
7.71×7.71×10.33×12.18×9.23×
20.0%20.0%19.1%13.3%18.2%
As filed — company-reported covenants
0.01×0.25×———
0.10×11.16×———
11.00×19.22×20.35×——
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

MEDICO₹18.98

Medico Remedies Limited

· Pharma & Health
₹ CrorePeersMEDICAMEQHALEOSLABSAAREYDRUGSNECLIFEALBERTDAVDVALIANTLABNATCAPSUQZIMLABMcap ₹158 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt9.88.114.718.818.8
Net Debt7.66.512.215.115.1
Total Debt/Equity0.220.150.240.250.25
Net Debt/Equity0.170.120.200.200.20
Total Debt/EBITDA1.010.620.981.111.11
Net Debt/EBITDA0.790.500.810.890.86
Interest Coverage (EBIT/Interest)9.2312.1810.337.717.71
Total Debt/Total Capital %18.2113.3219.0919.9719.97
As Filed — company-reported covenants
Debt/Equity (as filed)———0.250.01
Debt Service Coverage (as filed)———11.160.10
Interest Service Coverage (as filed)——20.3519.2211.00
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.